GFI1 and myeloproliferative disorder: Moreover, our finding that reduced Gfi1 expression levels almost exclusively orients the effect of both mutagenic agents, ENU and MMLV [1, 47–49], towards a myeloid leukemia is additional evidence that a low Gfi1 dose predisposes for MPN or AML.